ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients.
Ann Oncol
; 26(7): 1353-62, 2015 Jul.
Article
em En
| MEDLINE
| ID: mdl-25851629
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Proteínas Recombinantes
/
Neoplasias da Mama
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Interleucina-7
/
Carcinoma Lobular
/
Carcinoma Ductal de Mama
/
Linfopenia
Tipo de estudo:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article